25800891Krug LM, Kindler HL, Calvert H, Manegold C, Tsao AS, Fennell D, Öhman R, Plummer R, Eberhardt WE, Fukuoka K, Gaafar RM, Lafitte JJ, Hillerdal G, Chu Q, Buikhuisen WA, Lubiniecki GM, Sun X, Smith M, Baas PThe Lancet. OncologyAntineoplastic Combined Chemotherapy Protocols; Hydroxamic Acids; Lung Neoplasms; Mesothelioma; Neoplasm Recurrence, LocalAdult; Aged; Aged, 80 and over; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Kaplan-Meier Estimate; Male; Mesothelioma, Malignant; Middle Aged; Neoplasm Staging; Placebos; VorinostatVorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial. Lancet Oncol. 2015 Apr; 16(4):447-56.Lancet Oncol2015-03-20T00:00:002015Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial.prns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000369Living Beings93664810.461329Aged, 80 and overD000368Living Beings1341183530.29479AgedD000328Living Beings1578255770.254454AdultD000971Procedures30624340.47627Antineoplastic Combined Chemotherapy ProtocolsD004311Procedures33818220.70897Double-Blind MethodD006877Chemicals & Drugs40490.970912Hydroxamic AcidsD008654Disorders573090.774651MesotheliomaD008875Concepts & IdeasLiving Beings1473249570.258834Middle AgedD009367Concepts & IdeasProcedures34719320.6701Neoplasm StagingD008175Disorders32822600.404557Lung NeoplasmsD005260Physiology1992444050.191184FemaleD006801Living Beings2262862810.130064HumansD008297Physiology1931408600.201635MaleMedicine-Hematology and OncologyD009364Disorders33613050.619886Neoplasm Recurrence, LocalD010919DevicesProcedures982180.94867PlacebosD053208Concepts & Ideas3258590.818624Kaplan-Meier EstimateD064420Disorders1081990.823351Drug-Related Side Effects and Adverse ReactionsUniversity of ChicagoHedyKindler32lgBaUZHP75hHlsaUXv9Gq0+s+oHedy Kindler41.78927490000000-87.601250000000002499Kindler, HedyProfessortrue1ProfessorProfessorAuthorship 6861620.1337240.1337241authors10.2517has subject area